Results of multivariate analysis of outcomes and contributing factors
| Outcome . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| DFS | ||
| Identical sibling vs haploidentical | 0.83 (0.52-1.30) | .42 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 1.93 (1.18-3.15) | .008 |
| WBC >50 000 vs <50 000 per mm3 | 1.92 (1.21-3.04) | .005 |
| OS | ||
| Identical sibling vs haploidentical | 0.80 (0.47-1.37) | .43 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 0.62 (0.36-1.06) | .08 |
| WBC >50 000 vs <50 000 per mm3 | 0.51 (0.31-0.83) | .007 |
| Relapse | ||
| Identical sibling vs haploidentical | 1.06 (0.58-1.92) | .85 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 1.88 (1.05-3.76) | .04 |
| WBC >50 000 vs <50 000 per mm3 | 2.15 (1.18-3.91) | .01 |
| NRM | ||
| Identical sibling vs haploidentical | 0.58 (0.28-1.19) | .14 |
| Outcome . | Hazard ratio (95% CI) . | P . |
|---|---|---|
| DFS | ||
| Identical sibling vs haploidentical | 0.83 (0.52-1.30) | .42 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 1.93 (1.18-3.15) | .008 |
| WBC >50 000 vs <50 000 per mm3 | 1.92 (1.21-3.04) | .005 |
| OS | ||
| Identical sibling vs haploidentical | 0.80 (0.47-1.37) | .43 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 0.62 (0.36-1.06) | .08 |
| WBC >50 000 vs <50 000 per mm3 | 0.51 (0.31-0.83) | .007 |
| Relapse | ||
| Identical sibling vs haploidentical | 1.06 (0.58-1.92) | .85 |
| Other significant factors | ||
| Cytogenetic risk high vs intermediate | 1.88 (1.05-3.76) | .04 |
| WBC >50 000 vs <50 000 per mm3 | 2.15 (1.18-3.91) | .01 |
| NRM | ||
| Identical sibling vs haploidentical | 0.58 (0.28-1.19) | .14 |